Magnesium Chloride (magnesium chloride)
Magnesium Injection Vial (Ml)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Generic name: magnesium chloride
Drug class: Magnesium
Therapeutic class: Electrolyte Balance-Nutritional Products
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Magnesium Chloride
Indications
The following indications are listed for Magnesium Chloride:
- Hypomagnesemia
Also known as: Abnormally Decreased Blood Magnesium.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
Moderate Interaction: Assess the risk to the patient and take action as needed.
Magnesium Salts, Injectable/Nondepolarizing Muscle Relaxants
SEVERITY LEVEL: 3-Moderate Interaction: Assess the risk to the patient and take action as needed.
MECHANISM OF ACTION: Magnesium may reduce postjunctional membrane neuromuscular blocking action of nondepolarizing muscle relaxants. Parenterally administered magnesium may potentiate the effects of the nondepolarizing muscle relaxants.
CLINICAL EFFECTS: Increased neuromuscular blockade with profound sedation, respiratory depression, coma, and/or death.
PREDISPOSING FACTORS: None determined.
PATIENT MANAGEMENT: Monitor respiratory function when parenteral magnesium and nondepolarizing muscle relaxants are administered concurrently. Adjust the dose of the neuromuscular blocking agent accordingly. If concurrent use is necessary, monitor patients for unusual dizziness or lightheadedness, extreme sleepiness, slowed or difficult breathing, or unresponsiveness.
DISCUSSION: The effects of nondepolarizing muscle relaxants have been reported to be increased in laboratory animals and in humans by concomitant administration of magnesium sulfate. Respiratory depression has been reported.
Contraindications
There is no enhanced messaging for this drug.
- Hypermagnesemia
- Severe renal impairment
- Hypocalcemia
- Kidney disease with reduction in glomerular filtration rate (GFr)
- Myasthenia gravis
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
Rare or Very Rare
- Hypotension
- Hypothermia
- Injection site sequelae
- Respiratory depression
- Stupor
Rare or Very Rare
- Flushing
- Hyperhidrosis
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
| Code | Type | Description |
|---|---|---|
| Hypomagnesemia | ||
| E61.2 | ICD10CM | Magnesium deficiency |
| E83.42 | ICD10CM | Hypomagnesemia |
| P71.2 | ICD10CM | Neonatal hypomagnesemia |
ICD code information from First Databank (FDB).
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.